# SLM Corp: financial statements, quarterly

SLM · Nasdaq · CIK 1032033 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/slm.md) · [Financials](/companies/slm/financials.md) · [Filings](/companies/slm/filings.md) · [Insiders](/companies/slm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/slm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [283 d](/filings/0001628280-24-006382.md) | [277](/filings/0001628280-24-017666.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [56.8](/filings/0001628280-24-006382.md) | [97.6](/filings/0001628280-25-019704.md) | [86.6](/filings/0001032033-25-000012.md) | [(14.4)](/filings/0001032033-25-000033.md) | [20.6 d](/filings/0001032033-26-000011.md) | [98.6](/filings/0001032033-26-000025.md) | [16.4](/filings/0001032033-26-000042.md) | [50.0](/filings/0001032033-26-000052.md) | [82.8 d](/filings/0001032033-26-000011.md) | [92.4](/filings/0001032033-26-000025.md) | [21.9](/filings/0001032033-26-000042.md) | [(26.6)](/filings/0001032033-26-000052.md) |
| Net income | $m | [168](/filings/0001628280-24-006382.md) | [290](/filings/0001628280-25-019704.md) | [252](/filings/0001032033-25-000012.md) | [(45.2)](/filings/0001032033-25-000033.md) | [112 d](/filings/0001032033-26-000011.md) | [305](/filings/0001032033-26-000025.md) | [71.3](/filings/0001032033-26-000042.md) | [136](/filings/0001032033-26-000052.md) | [233 d](/filings/0001032033-26-000011.md) | [308](/filings/0001032033-26-000025.md) | [58.5](/filings/0001032033-26-000042.md) | [(32.3)](/filings/0001032033-26-000052.md) |
| Diluted EPS | $ per share | [0.72](/filings/0001628280-24-006382.md) | [1.27](/filings/0001628280-25-019704.md) | [1.11](/filings/0001032033-25-000012.md) | [(0.23)](/filings/0001032033-25-000033.md) | not reported | [1.40](/filings/0001032033-26-000025.md) | [0.32](/filings/0001032033-26-000042.md) | [0.63](/filings/0001032033-26-000052.md) | not reported | [1.54](/filings/0001032033-26-000025.md) | [0.29](/filings/0001032033-26-000042.md) | [(0.19)](/filings/0001032033-26-000052.md) |
| Basic EPS | $ per share | [0.73](/filings/0001628280-24-006382.md) | [1.29](/filings/0001628280-25-019704.md) | [1.13](/filings/0001032033-25-000012.md) | [(0.23)](/filings/0001032033-25-000033.md) | not reported | [1.43](/filings/0001032033-26-000025.md) | [0.32](/filings/0001032033-26-000042.md) | [0.64](/filings/0001032033-26-000052.md) | not reported | [1.56](/filings/0001032033-26-000025.md) | [0.29](/filings/0001032033-26-000042.md) | [(0.19)](/filings/0001032033-26-000052.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [4.1](/filings/0001032033-26-000011.md) | [3.6](/filings/0001628280-25-019704.md) | [5.3](/filings/0001032033-25-000012.md) | [4.5](/filings/0001032033-25-000033.md) | [4.7](/filings/0001032033-26-000011.md) | [3.7](/filings/0001032033-26-000025.md) | [4.1](/filings/0001032033-26-000042.md) | [3.5](/filings/0001032033-26-000052.md) | [4.2](/filings/0001032033-26-000052.md) | [5.2](/filings/0001032033-26-000025.md) | [4.6](/filings/0001032033-26-000042.md) | [2.2](/filings/0001032033-26-000052.md) |
| Total assets | $bn | [29.2](/filings/0001628280-25-006776.md) | [28.3](/filings/0001628280-24-017666.md) | [28.8](/filings/0001628280-24-033081.md) | [30.0](/filings/0001628280-24-043447.md) | [30.1](/filings/0001032033-26-000011.md) | [28.9](/filings/0001628280-25-019704.md) | [29.6](/filings/0001032033-25-000012.md) | [29.6](/filings/0001032033-25-000033.md) | [29.7](/filings/0001032033-26-000052.md) | [29.4](/filings/0001032033-26-000025.md) | [28.6](/filings/0001032033-26-000042.md) | [29.8](/filings/0001032033-26-000052.md) |
| Total liabilities | $bn | [27.3](/filings/0001628280-25-006776.md) | [26.2](/filings/0001628280-24-017666.md) | [26.5](/filings/0001628280-24-033081.md) | [27.9](/filings/0001628280-24-043447.md) | [27.9](/filings/0001032033-26-000011.md) | [26.5](/filings/0001628280-25-019704.md) | [27.2](/filings/0001032033-25-000012.md) | [27.3](/filings/0001032033-25-000033.md) | [27.3](/filings/0001032033-26-000052.md) | [27.0](/filings/0001032033-26-000025.md) | [26.1](/filings/0001032033-26-000042.md) | [27.6](/filings/0001032033-26-000052.md) |
| Long-term debt | $bn | [5.2](/filings/0001628280-25-006776.md) | [5.0](/filings/0001628280-24-017666.md) | [5.4](/filings/0001628280-24-033081.md) | [6.0](/filings/0001628280-24-043447.md) | [6.4](/filings/0001032033-26-000011.md) | [6.1](/filings/0001628280-25-019704.md) | [6.4](/filings/0001032033-25-000012.md) | [6.8](/filings/0001032033-25-000033.md) | [5.4](/filings/0001032033-26-000052.md) | [5.7](/filings/0001032033-26-000025.md) | [5.8](/filings/0001032033-26-000042.md) | [5.5](/filings/0001032033-26-000052.md) |
| Short-term borrowings | $bn | [0.0](/filings/0001628280-25-006776.md) | [0.0](/filings/0001628280-24-017666.md) | [0.0](/filings/0001628280-24-033081.md) | [0.0](/filings/0001628280-24-043447.md) | [0.0](/filings/0001032033-26-000011.md) | [0.0](/filings/0001628280-25-019704.md) | [0.0](/filings/0001032033-25-000012.md) | [0.0](/filings/0001032033-25-000033.md) | [0.5](/filings/0001032033-26-000052.md) | [0.5](/filings/0001032033-26-000025.md) | [0.0](/filings/0001032033-26-000042.md) | [0.9](/filings/0001032033-26-000052.md) |
| Shareholders' equity | $bn | [1.9](/filings/0001032033-26-000011.md) | [2.1](/filings/0001032033-25-000012.md) | [2.3](/filings/0001032033-25-000033.md) | [2.1](/filings/0001032033-25-000033.md) | [2.2](/filings/0001032033-26-000052.md) | [2.4](/filings/0001032033-26-000042.md) | [2.4](/filings/0001032033-26-000052.md) | [2.3](/filings/0001032033-26-000052.md) | [2.5](/filings/0001032033-26-000052.md) | [2.4](/filings/0001032033-26-000042.md) | [2.5](/filings/0001032033-26-000052.md) | [2.3](/filings/0001032033-26-000052.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(27.1) d](/filings/0001032033-26-000011.md) | [(76.7)](/filings/0001628280-25-019704.md) | [(144) d](/filings/0001032033-25-000012.md) | [(113) d](/filings/0001032033-25-000033.md) | [4.5 d](/filings/0001032033-26-000011.md) | [(146)](/filings/0001032033-26-000025.md) | [(139) d](/filings/0001032033-26-000042.md) | [(49.3) d](/filings/0001032033-26-000052.md) | [(64.5) d](/filings/0001032033-26-000011.md) | [(76.0)](/filings/0001032033-26-000025.md) | [(135) d](/filings/0001032033-26-000042.md) | [(106) d](/filings/0001032033-26-000052.md) |
| Dividends paid | $m | [24.4 d](/filings/0001032033-26-000011.md) | [24.3](/filings/0001628280-25-019704.md) | [24.0 d](/filings/0001032033-25-000012.md) | [23.5 d](/filings/0001032033-25-000033.md) | [27.3 d](/filings/0001032033-26-000011.md) | [27.5](/filings/0001032033-26-000025.md) | [27.2 d](/filings/0001032033-26-000042.md) | [26.9 d](/filings/0001032033-26-000052.md) | [26.2 d](/filings/0001032033-26-000011.md) | [25.6](/filings/0001032033-26-000025.md) | [24.5 d](/filings/0001032033-26-000042.md) | [24.0 d](/filings/0001032033-26-000052.md) |
| Share repurchases | $m | [90.9 d](/filings/0001032033-26-000011.md) | [25.5](/filings/0001628280-25-019704.md) | [61.0 d](/filings/0001032033-25-000012.md) | [114 d](/filings/0001032033-25-000033.md) | [47.1 d](/filings/0001032033-26-000011.md) | [29.7](/filings/0001032033-26-000025.md) | [71.7 d](/filings/0001032033-26-000042.md) | [144 d](/filings/0001032033-26-000052.md) | [124 d](/filings/0001032033-26-000011.md) | [291](/filings/0001032033-26-000025.md) | [3.1 d](/filings/0001032033-26-000042.md) | [128 d](/filings/0001032033-26-000052.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [244](/filings/0001628280-24-017666.md) | [238](/filings/0001628280-24-033081.md) | [229](/filings/0001628280-24-043447.md) | [224](/filings/0001628280-25-019704.md) | [222](/filings/0001032033-25-000012.md) | [215](/filings/0001032033-25-000033.md) | [215](/filings/0001032033-26-000025.md) | [213](/filings/0001032033-26-000042.md) | [211](/filings/0001032033-26-000052.md) | [198](/filings/0001032033-26-000025.md) | [190](/filings/0001032033-26-000042.md) | [186](/filings/0001032033-26-000052.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 182,821,173 at 2026-09-30, from the cover of the [10-Q filed 2026-10-22](/filings/0001032033-26-000052.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.